Nestle India (NEST IN) Altius, Citius, Fortius
|
|
- Charles Lang
- 5 years ago
- Views:
Transcription
1 INSTITUTIONAL EQUITY RESEARCH Nestle India (NEST IN) Altius, Citius, Fortius INDIA FMCG Company Update We attended Nestle analyst meet yesterday and came pretty impressed with 1) management agility on doing required (innovation, focus on new channels, withdrawing new products if not getting traction) for driving growth within existing categories, 2) foray into fast-growing new categories (breakfast cereals, nutrition supplement category) and satisfactory reply from management as why Pet care business has been launched thorough Nestle SA (Parent), which had been concern area for us and 3) adopting cluster based approach for driving distribution related efficiencies. We upgrade to BUY from Neutral with revised TP of Rs 12, (55x Sept-2 EPS) vs Rs 1,875 (5x Sept-2 EPS) earlier Core categories NPD / channel expansion to continue: Management highlighted core categories continue to see healthy traction owing to market share gains (in noodles, beverages category), new product launches (65% of the launches got decent traction) and further expansion into newer channels (e-commerce, out of home market). Nestle has withdrawn 11 new launches out of 39 launches made so far (which were introduced post new MD s induction in August,215) from the market, as the products were either ahead of time or there was miscommunication from the company s side on actual purpose/intend of the product. Contribution of NPD to total sales has increased from 2.8% in 1HCY17 to 3% in 1HCY18. Foray into fast growing new categories: Nestle entry into breakfast cereals (market size expected to reach Rs 32 bn in 22 from Rs 21 bn in 217) and health/nutrition supplements category (market size of Rs 15-2 bn) seems to be encouraging as it has right to win in these categories. We were fully satisfied with management s reply - capabilities/skills, nature of business and route to market are completely different for Pet care business from core FMCG business and therefore launched thorough Nestle SA (parent) ; not thorough listed Indian arm. Nesplus breakfast cereals (customized product/formulation), despite being product of global JV between Nestle SA and General Mills has been incubated in Nestle India as local management has required expertise in this line of business Cluster based distribution approach to unleash next leg of growth Nestle has decided to create 15 distribution clusters within India (something similar HUL did in 214 thorough Winning In Many India approach). HUL saw healthy traction (gross sales grew 9.4% Cagr over FY14-16) post it transformed from four branch structure to 14 cluster approach. We believe Nestle is also likely to follow the suit as granular understanding of customer profile, competitors and products will enable local management to devise strategy which could drive growth in semi-urban/ rural areas (Nestle Rural contribution is only c15-2% vs Industry contribution of c35-4%). Scarcity Premium within F&B space to support rich valuations : We had got too bogged down by rich valuations despite strong business outlook and downgraded our rating to Neutral from BUY post 2QCY18 results and we believe post analyst meet, it is too difficult to pin down the impact of fresh qualitative factors into financials nos; although we have tried our level best 1) management new found aggression with regards to foray into newer categories 2) re-jigging distribution structure, thereby empowering local team to take required action to combat competition and 3) success of new product launches in existing categories. Hence, we increased our PE multiple from 5x to 55x to incorporate the above mentioned observations and upgrade our rating to BUY from Neutral with revised TP of Rs 12, vs 1,875 (5x Sept -2 EPS) earlier. 22 August 218 BUY (Upgrade) CMP RS 1,888 TARGET RS 12, (1%) COMPANY DATA O/S SHARES (MN) : 96 MARKET CAP (RSBN) : 137 MARKET CAP (USDBN) : WK HI/LO (RS) : 1888/641 LIQUIDITY 3M (USDMN) : 8.3 PAR VALUE (RS) : 1 SHARE HOLDING PATTERN, % Jun 18 Mar 18 Dec 17 PROMOTERS : FII / NRI : FI / MF : NON PRO : PUBLIC & OTHERS : KEY FINANCIALS Rs mn CY18E CY19E CY2E Net Sales 114, , ,547 EBIDTA 26,9 3,639 35,811 Net Profit 15,431 18,438 21,81 EPS, Rs PER, x EV/EBIDTA, x ROE, % Debt/Equity (%) PhillipCapital India values your support in the Asiamoney Brokers Poll 218. We appreciate your vote. Vishal Gutka ( ) vgutka@phillipcapital.in Naveen Kulkarni ( ) nkulkarni@phillipcapital.in Preeyam Tolia ( ) ptolia@phillipcapital.in Risks to our call 1) Sharper than expected inflation in RM index 2) Nestle not getting desired traction as far as new launches / foray into new categories is concerned. Page 1 PHILLIPCAPITAL INDIA RESEARCH
2 Volume growth momentum continues Volume gr (%) Q1CY17 Q2CY17 Q3CY17 Q4CY17 Q1CY18 Q2CY18 Nestle makes healthy gains in Noodles, Pasta and Beverages categories Category Brand MAT (Jul 16-Jun 17) MAT (Jul 17-Jun 18) Change (yoy) Instant Noodles Maggi bps Ketchups & Sauces Maggi bps Instant Pasta Maggi bps Infant Formula Lactogen & NAN bps Infant Cereals Nestle Cerelac bps Tea Creamer Every Day bps Chocolates Nestle bps White & Wafers Kitkat, Munch, Milky Bar bps Instant Coffee Nescafe bps Maggi s portfolio rebuilt brick by brick Maggi Noodles (Sales Index) Q1CY16 Q2CY16 Q3CY16 Q4CY16 Q1CY17 Q2CY17 Q3CY17 Q4CY17 Q1CY18 Q2CY18 Page 2 PHILLIPCAPITAL INDIA RESEARCH
3 Prepared dishes, beverages saw healthy volume growth Category Volume growth (%) Contribution (%) Milk Products & Nutrition Prepared Dishes Confectionery Powdered & Liquid Beverages Entry into fast growing categories Breakfast Cereals Health/Nutrition supplements Source: Company New product launches calendar Month Product Category Aug-18 Maggi Special Masala Noodles Noodles Jul-18 NESPLUS -Kokos, Choco-Burst Fillows, Strawberry Burst Fillows, Nutty Breakfast Cereals Honey Mar-18 Munch - Crunch-O-Nuts Chocolates Feb-18 Kitkat - Strawberry Duo Chocolates Sep-17 Kit Kat Dessert Delight Chocolates Aug-17 Maggi Nutri-Licious noodle Noodles Iron-fortified Maggi Noodles to make maggi healthier under simply Noodles good 22 initiative Nestle A+ Grekyo (Blueberry Greek Yogurt/ Greek Style Curd) Yogurt May-17 Maggi Masala (AmritsariAchari, MumbaiyaChatak, Super Chennai, Noodles Bengali Jhaal) Mar-17 Milo Ready to Drink Beverages Oct-16 Nescafe Ready to Drink Beverages Nestle A+ Pro-Grow Milk & Nutrition Maggi CUPPA Masala/Chilly Chow/ Hot Heads Noodles Maggi No Onion No Garlic Masala Noodles Aug-16 Maggi Hot Head, Noodles Nescafe Sunrise Insta- Filter Beverages Apr-16 Nestle A+ Grekyo Yogurt Yogurt Page 3 PHILLIPCAPITAL INDIA RESEARCH
4 Benign commodity costs drove margin expansion; however lately some commodities (wheat, sugar and milk) have started seeing inflationary trends which may halt margin gains in medium term Commodity Inflation H1'CY Milks Wheat Coffee Palm Oil Sugar DWP MSK Palm Kernel Source: PhillipCapital India Research Raw material mix Palm kernel, 3% Others, 17% DWP, 4% MSK, 4% Milk, 37% Sugar, 6% Palm oil, 7% Green Coffee, 1% Wheat Flour, 12% Source: PhillipCapital India Research East (due to high salience to milk category) has a larger share Region wise domestic sales contribution (%) 1.2 E-com contribution to domestic sales (%) 1.1 South, 24% East, 31% North, 27% West, 18%.2 H1'CY17 H1'CY18 Source: PhillipCapital India Research Page 4 PHILLIPCAPITAL INDIA RESEARCH
5 Region wise comparable growth 18% 16% 14% 16.2% Region wise comparable growth (%) - H1'CY % 14.6% 12% 1% 1.4% 8% 6% 4% 2% % East West North South Source: PhillipCapital India Research Two-year forward P/E Band EV/EBITDA band 14 Rs P/E 12 6x 16 Rs mn EV/EBITDA 14 4x x 3x 15x x 2x 1x 2 2 Source: PhillipCapital India Research Estimate Page 5 PHILLIPCAPITAL INDIA RESEARCH
6 Financials Income Statement Y/E Mar, Rs mn CY17 CY18E CY19E CY2E Net sales 99, , , ,547 Growth, % Total income 99, , , ,547 Raw material expenses -43,269-49,124-55,252-62,664 Employee expenses -1,175-11,452-12,827-14,418 Other Operating expenses -24,439-27,628-3,933-34,655 EBITDA (Core) 21,643 26,9 3,639 35,811 Growth, % Margin, % Depreciation -3,794-3,97-4,133-4,359 EBIT 17,849 22,11 26,56 31,452 Growth, % Margin, % Interest paid Other Non-Operating Income 1,769 1,858 1,951 2,48 Pre-tax profit 17,822 23,31 27,519 32,553 Tax provided -6,141-7,6-9,81-1,742 Profit after tax 11,681 15,431 18,438 21,81 Net Profit 11,681 15,431 18,438 21,81 Growth, % Net Profit (adjusted) 11,681 15,431 18,438 21,81 Unadj. shares (m) Wtdavg shares (m) Balance Sheet Y/E Mar, Rs mn CY17 CY18E CY19E CY2E Cash & bank 14,574 38,2 45,246 53,61 Debtors 89 1,15 1,152 1,311 Inventory 9,25 1,326 11,722 13,34 Loans & advances Total current assets 25,15 5,23 58,782 68,923 Investments 19,789 5,853 5,853 5,853 Gross fixed assets 33,584 35,584 37,584 39,584 Less: Depreciation -7,423-11,33-15,463-19,822 Add: Capital WIP Net fixed assets 27,13 25,196 23,63 2,74 Total assets 73,626 82,836 89,281 97,63 Current liabilities 14,53 15,471 16,994 18,759 Total current liabilities 37,843 42,614 47,688 53,569 Non-current liabilities 1,577 1,577 1,577 1,577 Total liabilities 39,42 44,191 49,265 55,146 Paid-up capital Reserves & surplus 33,242 37,868 39,24 41,14 Shareholders equity 34,26 38,644 4,16 41,917 Total equity & liabilities 73,626 82,836 89,281 97,63 Estimates Cash Flow CY17 CY18E CY19E CY2E Pre-tax profit 17,822 23,31 27,519 32,553 Depreciation 3,794 3,97 4,133 4,359 Chg in working capital 4,799 3,345 3,541 4,14 Total tax paid -6,475-7,6-9,81-1,742 Cash flow from operating activities 18,178 22,682 26,111 3,274 Capital expenditure -1,714-2, -2, -2, Chg in investments -2,232 13,936 Cash flow from investing activities -1,36-2, -2, -2, Free cash flow 16,872 2,682 24,111 28,274 Debt raised/(repaid) 2 Dividend (incl. tax) -9,98-1,991-17,66-19,91 Cash flow from financing activities -9,966-1,991-17,66-19,91 Net chg in cash 6,96 9,691 7,46 8,364 Valuation Ratios CY17 CY18E CY19E CY2E Per Share data EPS (INR) Growth, % Book NAV/share (INR) FDEPS (INR) CEPS (INR) CFPS (INR) DPS (INR) Return ratios Return on assets (%) Return on equity (%) Return on capital employed (%) Turnover ratios Asset turnover (x) Sales/Total assets (x) Sales/Net FA (x) Working capital/sales (x) (.) (.) (.) (.) Fixed capital/sales (x) Working capital days (12.8) (11.1) (9.7) (8.5) Liquidity ratios Current ratio (x) Quick ratio (x) Interest cover (x) Dividend cover (x) Total debt/equity (%) Net debt/equity (%) (41.6) (97.9) (112.2) (127.1) Valuation PER (x) Price/Book (x) EV/Net sales (x) EV/EBITDA (x) EV/EBIT (x) Page 6 PHILLIPCAPITAL INDIA RESEARCH
7 Stock Price, Price Target and Rating History B (TP 12) S (TP 547) S (TP S 543) (TP S (TP 545) 545) B (TP 543) S (TP 59) S (TP 6) B (TP 77) B (TP 84) B (TP 84) 5 S (TP 45) J-15 S (TP 547) S-15 O-15 D-15 J-16 M-16 A-16 J-16 J-16 S-16 O-16 D-16 J-17 F-17 A-17 M-17 J-17 A-17 O-17 N-17 J-18 F-18 A-18 M-18 J-18 Rating Methodology We rate stock on absolute return basis. Our target price for the stocks has an investment horizon of one year. Rating Criteria Definition BUY >= +15% Target price is equal to or more than 15% of current market price NEUTRAL -15% > to < +15% Target price is less than +15% but more than -15% SELL <= -15% Target price is less than or equal to -15%. Page 7 PHILLIPCAPITAL INDIA RESEARCH
8 Disclosures and Disclaimers PhillipCapital (India) Pvt. Ltd. has three independent equity research groups: Institutional Equities, Institutional Equity Derivatives, and Private Client Group. This report has been prepared by Institutional Equities Group. The views and opinions expressed in this document may, may not match, or may be contrary at times with the views, estimates, rating, and target price of the other equity research groups of PhillipCapital (India) Pvt. Ltd. This report is issued by PhillipCapital (India) Pvt. Ltd., which is regulated by the SEBI. PhillipCapital (India) Pvt. Ltd. is a subsidiary of Phillip (Mauritius) Pvt. Ltd. References to "PCIPL" in this report shall mean PhillipCapital (India) Pvt. Ltd unless otherwise stated. This report is prepared and distributed by PCIPL for information purposes only, and neither the information contained herein, nor any opinion expressed should be construed or deemed to be construed as solicitation or as offering advice for the purposes of the purchase or sale of any security, investment, or derivatives. The information and opinions contained in the report were considered by PCIPL to be valid when published. The report also contains information provided to PCIPL by third parties. The source of such information will usually be disclosed in the report. Whilst PCIPL has taken all reasonable steps to ensure that this information is correct, PCIPL does not offer any warranty as to the accuracy or completeness of such information. Any person placing reliance on the report to undertake trading does so entirely at his or her own risk and PCIPL does not accept any liability as a result. Securities and Derivatives markets may be subject to rapid and unexpected price movements and past performance is not necessarily an indication of future performance. This report does not regard the specific investment objectives, financial situation, and the particular needs of any specific person who may receive this report. Investors must undertake independent analysis with their own legal, tax, and financial advisors and reach their own conclusions regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realised. Under no circumstances can it be used or considered as an offer to sell or as a solicitation of any offer to buy or sell the securities mentioned within it. The information contained in the research reports may have been taken from trade and statistical services and other sources, which PCIL believe is reliable. PhillipCapital (India) Pvt. Ltd. or any of its group/associate/affiliate companies do not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice. Important: These disclosures and disclaimers must be read in conjunction with the research report of which it forms part. Receipt and use of the research report is subject to all aspects of these disclosures and disclaimers. Additional information about the issuers and securities discussed in this research report is available on request. Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the research analyst s personal views about all of the subject issuers and/or securities, that the analyst(s) have no known conflict of interest and no part of the research analyst s compensation was, is, or will be, directly or indirectly, related to the specific views or recommendations contained in this research report. Additional Disclosures of Interest: Unless specifically mentioned in Point No. 9 below: 1. The Research Analyst(s), PCIL, or its associates or relatives of the Research Analyst does not have any financial interest in the company(ies) covered in this report. 2. The Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the company (ies)covered in this report as of the end of the month immediately preceding the distribution of the research report. 3. The Research Analyst, his/her associate, his/her relative, and PCIL, do not have any other material conflict of interest at the time of publication of this research report. 4. The Research Analyst, PCIL, and its associates have not received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in this report, in the past twelve months. 5. The Research Analyst, PCIL or its associates have not managed or co-managed in the previous twelve months, a private or public offering of securities for the company (ies) covered in this report. 6. PCIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in connection with the research report. 7. The Research Analyst has not served as an Officer, Director, or employee of the company (ies) covered in the Research report. 8. The Research Analyst and PCIL has not been engaged in market making activity for the company(ies) covered in the Research report. 9. Details of PCIL, Research Analyst and its associates pertaining to the companies covered in the Research report: Sr. no. Particulars Yes/No 1 Whether compensation has been received from the company(ies) covered in the Research report in the past 12 months for No investment banking transaction by PCIL 2 Whether Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively hold more than 1% of No the company(ies) covered in the Research report 3 Whether compensation has been received by PCIL or its associates from the company(ies) covered in the Research report No 4 PCIL or its affiliates have managed or co-managed in the previous twelve months a private or public offering of securities for the No company(ies) covered in the Research report 5 Research Analyst, his associate, PCIL or its associates have received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in the Research report, in the last twelve months No Independence: PhillipCapital (India) Pvt. Ltd. has not had an investment banking relationship with, and has not received any compensation for investment banking services from, the subject issuers in the past twelve (12) months, and PhillipCapital (India) Pvt. Ltd does not anticipate receiving or intend to seek compensation for investment banking services from the subject issuers in the next three (3) months. PhillipCapital (India) Pvt. Ltd is not a market maker in the securities mentioned in this research report, although it, or its affiliates/employees, may have positions in, purchase or sell, or be materially interested in any of the securities covered in the report. Suitability and Risks: This research report is for informational purposes only and is not tailored to the specific investment objectives, financial situation or particular requirements of any individual recipient hereof. Certain securities may give rise to substantial risks and may not be suitable for certain investors. Each investor must make its own determination as to the appropriateness of any securities referred to in this research report based upon the legal, tax and accounting considerations applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The value of any security may be positively or adversely affected by changes in foreign exchange or interest rates, as well as by other financial, economic, or political factors. Past performance is not necessarily indicative of future performance or results. Page 8 PHILLIPCAPITAL INDIA RESEARCH
9 Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be reliable, but neither PCIPL nor the research analyst represents or guarantees that the information contained herein is accurate or complete and it should not be relied upon as such. Opinions expressed herein are current opinions as of the date appearing on this material, and are subject to change without notice. Furthermore, PCIPL is under no obligation to update or keep the information current. Without limiting any of the foregoing, in no event shall PCIL, any of its affiliates/employees or any third party involved in, or related to computing or compiling the information have any liability for any damages of any kind including but not limited to any direct or consequential loss or damage, however arising, from the use of this document. Copyright: The copyright in this research report belongs exclusively to PCIPL. All rights are reserved. Any unauthorised use or disclosure is prohibited. No reprinting or reproduction, in whole or in part, is permitted without the PCIPL s prior consent, except that a recipient may reprint it for internal circulation only and only if it is reprinted in its entirety. Caution: Risk of loss in trading/investment can be substantial and even more than the amount / margin given by you. Investment in securities market are subject to market risks, you are requested to read all the related documents carefully before investing. You should carefully consider whether trading/investment is appropriate for you in light of your experience, objectives, financial resources and other relevant circumstances. PhillipCapital and any of its employees, directors, associates, group entities, or affiliates shall not be liable for losses, if any, incurred by you. You are further cautioned that trading/investments in financial markets are subject to market risks and are advised to seek independent third party trading/investment advice outside PhillipCapital/group/associates/affiliates/directors/employees before and during your trading/investment. There is no guarantee/assurance as to returns or profits or capital protection or appreciation. PhillipCapital and any of its employees, directors, associates, and/or employees, directors, associates of PhillipCapital s group entities or affiliates is not inducing you for trading/investing in the financial market(s). Trading/Investment decision is your sole responsibility. You must also read the Risk Disclosure Document and Do s and Don ts before investing. Kindly note that past performance is not necessarily a guide to future performance. For Detailed Disclaimer: Please visit our website For U.S. persons only: This research report is a product of PhillipCapital (India) Pvt Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S.-regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances, and trading securities held by a research analyst account. This report is intended for distribution by PhillipCapital (India) Pvt Ltd. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by the U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated, and/or transmitted onward to any U.S. person, which is not a Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, PhillipCapital (India) Pvt Ltd. has entered into an agreement with a U.S. registered broker-dealer, Decker & Co, LLC. Transactions in securities discussed in this research report should be effected through Decker & Co, LLC or another U.S. registered broker dealer. If Distribution is to Australian Investors This report is produced by PhillipCapital (India) Pvt Ltd and is being distributed in Australia by Phillip Capital Limited (Australian Financial Services Licence No ). This report contains general securities advice and does not take into account your personal objectives, situation and needs. Please read the Disclosures and Disclaimers set out above. By receiving or reading this report, you agree to be bound by the terms and limitations set out above. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately. PhillipCapital (India) Pvt. Ltd. Registered office: No. 1, 18th Floor, Urmi Estate, 95 Ganpatrao Kadam Marg, Lower Parel West, Mumbai 413 Page 9 PHILLIPCAPITAL INDIA RESEARCH
KDDL (KDDL IN) In expansion mode
INSTITUTIONAL EQUITY RESEARCH KDDL (KDDL IN) In expansion mode INDIA MIDCAP Quarterly Update Top takeaways from 2QFY19 Results in line, recovery in manufacturing & strong growth in precision engineering.
More informationColgate Palmolive (CLGT IN) Volume growth revival is the biggest positive
INSTITUTIONAL EQUITY RESEARCH Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive INDIA FMCG Quarterly Update Top takeaways from Q2FY19 In line results. Benefits of gross margin improvement
More informationIndo Count (ICNT IN) Cost and currency impacted the margins
INSTITUTIONAL EQUITY RESEARCH Indo Count (ICNT IN) Cost and currency impacted the margins INDIA MIDCAP TEXTILE Quarterly Update Top takeaways from 2QFY19 Results were lower than estimates on margin decline,
More informationThe India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power
INSTITUTIONAL EQUITY RESEARCH The India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power INDIA CEMENT Quarterly Update 12 November 218 Top takeaways from Q2FY19
More informationBHEL (BHEL IN) Weak execution and margins lead to the miss in earnings
INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings INDIA CAPITAL GOODS Quarterly Update 26 October 2018 Top takeaways from 2QFY19 BHEL s reported earnings
More informationCG Power (CGPOWER IN) Analyst meet takeaways
INSTITUTIONAL EQUITY RESEARCH CG Power (CGPOWER IN) Analyst meet takeaways INDIA CAPITAL GOODS Company Update 22 November 2018 We recently interacted with the management of CG Power to better understand
More informationManappuram Finance (MGFL IN) Healthy operating performance
INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Healthy operating performance INDIA BFSI Quarterly Update Top takeaways from Q2FY19 Operating results ahead of expectations with NII/PAT at Rs
More informationCeat Ltd (CEAT IN) Competitive scenario easing?
INSTITUTIONAL EQUITY RESEARCH Ceat Ltd (CEAT IN) Competitive scenario easing? INDIA AUTOMOBILES Company Update Ceat has underperformed its peers CYTD with the stock falling by more than 25% mainly because
More informationManappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability
INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability INDIA BFSI Quarterly Update Top takeaways from Q1FY19 Operating results inline
More informationAtul Ltd (ATLP IN) Sustained price & AkzoNobel JV to drive value growth
INSTITUTIONAL EQUITY RESEARCH Atul Ltd (ATLP IN) Sustained price & AkzoNobel JV to drive value growth INDIA SPECIALTY CHEMICALS Quarterly Update Top takeaways from Q3FY19 Standalone sales at Rs 10.19bn
More informationLarsen & Toubro (LT IN) Shines on all parameters and we get constructive
INSTITUTIONAL EQUITY RESEARCH Larsen & Toubro (LT IN) Shines on all parameters and we get constructive INDIA CAPITAL GOODS Quarterly Update Top takeaways from 2QFY19 Recurring PAT (Rs 19.4bn, 15% yoy)
More informationBHEL (BHEL IN) Margins continue to disappoint
INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Margins continue to disappoint INDIA CAPITAL GOODS Quarterly Update 6 February 2019 Top takeaways from 3QFY19 BHEL s recurring earnings (Rs 2.8bn; +31% yoy)
More informationLarsen & Toubro (LT IN) Well played on all fronts but for margins
INSTITUTIONAL EQUITY RESEARCH Larsen & Toubro (LT IN) Well played on all fronts but for margins INDIA CAPITAL GOODS Quarterly Update Top takeaways from 3QFY19 Recurring PAT (Rs 20.4bn, 36% yoy) was 20%/8%
More informationInfosys (INFO IN) Strong performance; small miss on margins maintain BUY
INSTITUTIONAL EQUITY RESEARCH Infosys (INFO IN) Strong performance; small miss on margins maintain BUY INDIA IT SERVICES Quarterly Update 11 January 2019 Infosys reported mix set of numbers this quarter
More informationNIIT Technologies (NITEC IN) Strong performance across the board; maintain BUY
INSTITUTIONAL EQUITY RESEARCH NIIT Technologies (NITEC IN) Strong performance across the board; maintain BUY INDIA IT SERVICES Quarterly Update NIIT Tech reported strong performance in this quarter delivering
More informationAsian Paints (APNT IN) Not a colorful performance
INSTITUTIONAL EQUITY RESEARCH Asian Paints (APNT IN) Not a colorful performance INDIA FMCG Quarterly Update Top takeaways from Q2FY19 Results were significantly below our estimates as: (1) it deferred
More informationHDFC Bank (HDFCB IN) Continue to perform strong
INSTITUTIONAL EQUITY RESEARCH HDFC Bank (HDFCB IN) Continue to perform strong INDIA FINANCIALS Quarterly Update Top takeaways from Q3FY19 Earnings were in line with estimate. NII growth at 22% (vs expectation
More informationAarti Industries (ARTO IN) A structural specialty chemical growth play
INSTITUTIONAL EQUITY RESEARCH Aarti Industries (ARTO IN) A structural specialty chemical growth play INDIA SPECIALTY CHEMICALS Company Update We recently visited ARTO s plant in Jhagadia (Gujarat). This
More informationHindustan Unilever Ltd (HUVR IN) Gross margin pressure managed well
INSTITUTIONAL EQUITY RESEARCH Hindustan Unilever Ltd (HUVR IN) Gross margin pressure managed well INDIA FMCG Quarterly Update Top takeaways from Q2FY19 HUL saw its fourth consecutive quarter of double
More informationEmami (HMN IN) Seasonality jinx continues
INSTITUTIONAL EQUITY RESEARCH Emami (HMN IN) Seasonality jinx continues INDIA FMCG Quarterly Update 1 February 2019 Despite gross-margin pressure Emami s 3QFY19 was slightly above our estimates due to
More informationPhillipCapital-Actionable Trades (P-ACT)
Alternative Research INDIA 13 October 2017 armg@phillipcapital.in DAILY REPORT PhillipCapital-Actionable Trades (P-ACT) KEY POINTS» Outlook & Chart» Sharp Shooter Trading & Delivery Trades» Silent Samurai
More informationICICI Bank (ICICIBC IN) Strong improvement in asset quality
INSTITUTIONAL EQUITY RESEARCH ICICI Bank (ICICIBC IN) Strong improvement in asset quality INDIA FINANCIALS Quarterly Update Top takeaways from Q3FY19 ICICI Bank s reported Profit after tax of Rs 16bn,
More informationIT Services Deal Monitor: ISG 3QCY18 Takes a breather
INSTITUTIONAL EQUITY RESEARCH IT Services Deal Monitor: ISG 3QCY18 Takes a breather INDIA IT SERVICES Quarterly Update ISG announced the Q3CY18 dealflow data yesterday. The strong deal momentum of the
More informationCamlin Fine Sciences (CFIN IN) At the inflexion point
INSTITUTIONAL EQUITY RESEARCH Camlin Fine Sciences (CFIN IN) At the inflexion point INDIA SPECIALTY CHEMICALS Quarterly Update Top takeaways from Q2FY19 Consolidated sales at Rs 2.01bn (5% miss to our
More informationdepreciation the stood at 1.4x 2%) positive impacted by impact of INR share in the room duty continue to UCP vs months
INSTITUTIONAL EQUITY Voltas Limited (VOLT IN) Strong project execution made up for a weak AC business INDIA CAPITAL GOODS Quarterly Update 7 vember 2018 Top takeaways from 2QFY19 Recurring PAT (Rs 1bn,
More informationNestlé India Outlook Hazy; Valuations Prohibitive
Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India s net sales, EBITDA and net profit surged by 35% yoy, 67% yoy & 116% yoy to Rs23.5bn, Rs4.5bn & Rs2.7bn, respectively in 3QCY16. This growth
More informationNestle India (NEST IN)
(NEST IN) Rating: HOLD CMP: Rs11,363 TP: Rs10,996 August 24, 2018 Analyst Meet Update Change in Estimates Target Reco Change in Estimates Current Previous CY19E CY20E CY19E CY20E Rating HOLD UNDER REVIEW
More informationNestle India Ltd. RESULT UPDATE
RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside
More informationNestlé India. Q2CY17 Result Update. Positives priced in; Downgrade to Hold. Sector: FMCG CMP: ` 6,786. Recommendation: HOLD
Nestlé India Q2CY17 Result Update Positives priced in; Downgrade to Hold Sector: FMCG CMP: ` 6,786 Recommendation: HOLD Market statistics Current stock price (`) 6,786 Shares O/S (cr.) 9.6 Mcap (`cr) 65,424
More informationHOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017
2QCY17 Result Update July 27,2017 Market Cap. (Rs bn) 657 Free Float (%) 37.3 Shares O/S (mn) 96 Good Performance Irrespective of GST Pangs Nestlé India has reported a good set of numbers for 2QCY17 in
More informationNestlé India. Q4CY16 Result Update. Healthy Sales growth; higher provisions & CSR impacts bottom-line. Sector: FMCG CMP: ` 6,169. Recommendation: BUY
Nestlé India Q4CY16 Result Update Healthy Sales growth; higher provisions & CSR impacts bottom-line Sector: FMCG CMP: ` 6,169 Recommendation: BUY Market statistics Current stock price (`) 6,169 Shares
More informationNestle India (NEST IN)
(NEST IN) Rating: ACCUMULATE CMP: Rs9,569 TP: Rs11,129 October 26, 2018 Q3CY18 Result Update Change in Estimates Target Reco Change in Estimates Current Previous CY19E CY20E CY19E CY20E Rating ACCUMULATE
More informationNestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%
1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven
More informationIndia Strategy Adding currency play to consumption
INSTITUTIONAL EQUITY RESEARCH India Strategy Adding currency play to consumption INDIA STRATEGY 2 August 218 Rupee has weakened past 7 led by dollar strength. While Indian economic fundamentals remain
More informationMahindra & Mahindra (MM IN) Robust quarter, largely in line
INSTITUTIONAL EQUITY RESEARCH Mahindra & Mahindra (MM IN) Robust quarter, largely in line INDIA AUTOMOBILES Quarterly Update Top takeaways from Q1FY19 Revenue at Rs 134bn was largely in line EBITDA at
More informationCMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212
2QCY17 Result Update July 20, 2017 Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212 Well-placed in Power T&D Hi-tech Space; Order Book Remains Robust India s revenue rose by 6.0% YoY to Rs23.3bn
More informationABB India (ABB IN) Bottom cycle valuation despite stable outlook
INSTITUTIONAL EQUITY RESEARCH ABB India (ABB IN) Bottom cycle valuation despite stable outlook INDIA CAPITAL GOODS Quarterly Update Top takeaways from 2QCY18 ABB's 2QCY18 PAT (Rs 1bn, +36% yoy) was 12%
More informationNalco (NACL IN) Alumina volumes drive profits
INSTITUTIONAL EQUITY RESEARCH Nalco (NACL IN) Alumina volumes drive profits INDIA METALS Quarterly Update Top takeaways from Q4FY18 Net sales at Rs 28.6bn was 2% above estimates as higher alumina sales
More informationCMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133
4QFY17 Result Update June 06, 2017 Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 Mixed Quarterly Performance; Volume to Remain Strong has reported a mixed performance in 4QFY17. Its blended
More informationKey estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,
: price: EPS: How does our one year outlook change? We retain our positive view on EIM on the back of expected improvement in volume and margin at Royal Enfield (RE) and expected revival in VECV on the
More informationSource: Company Data; PL Research
Strong inflow growth, renewable/railways key drivers October 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,063
More informationRamkrishna Forgings (RMKF IN) Marginally ahead, story intact
INSTITUTIONAL EQUITY RESEARCH Ramkrishna Forgings (RMKF IN) Marginally ahead, story intact INDIA AUTOMOBILES Quarterly Update Top takeaways from Q4FY18 Revenue at Rs 4.4bn up 10% qoq (+52% yoy) was 1%
More informationBHEL (BHEL IN) Elevated provisions and taxes led to the disappointment
INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Elevated provisions and taxes led to the disappointment INDIA CAPITAL GOODS Quarterly Update 30 May 2018 Top takeaways from 4QFY18 BHEL s recurring profit (Rs
More informationVoltas Limited (VOLT IN) Higher margins offset weak revenues
INSTITUTIONAL EQUITY RESEARCH Voltas Limited (VOLT IN) Higher margins offset weak revenues INDIA CAPITAL GOODS Quarterly Update 17 May 2018 Top takeaways from 4QFY18 Recurring PAT (Rs 1.94bn, 2% yoy) was
More informationIndia Banking Trends Q2FY19 results review: Early signs of the credit cost cycle normalising
INSTITUTIONAL EQUITY RESEARCH India Banking Trends Q2FY19 results review: Early signs of the credit cost cycle normalising INDIA FINANCIAL FORTNIGHTLY Private corporate banks outperformed: PBT for banks
More informationLarsen & Toubro (LT IN) In line results; current orders momentum is a positive
INSTITUTIONAL EQUITY RESEARCH Larsen & Toubro (LT IN) In line results; current orders momentum is a positive INDIA CAPITAL GOODS Quarterly Update Top takeaways from 4QFY18 Recurring PAT (Rs 31.8bn, flat
More informationTVS Motors. Source: Company Data; PL Research
Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709
More informationCMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7
2QFY18 Result Update November 23, 2017 Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7 High Order Book Provides Revenue Visibility (PMPL) has delivered a healthy performance in 2QFY18.
More informationMonetary Policy A sound monetary policy on all parameters after a long time
Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18 Dec-18 Dec-13 Jun-14 Dec-14 Jun-15 Dec-15 Jun-16 Dec-16 Jun-17 Dec-17 Jun-18 Dec-18 Mar-10 Jun-11 Sep-12 Dec-13 Mar-15 Jun-16 Sep-17 Dec-18 INSTITUTIONAL
More informationMaruti Suzuki. Source: Company Data; PL Research
Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty
More informationNarnolia Securities Ltd. RAJEEV ANAND 28-Jul-17
28-Jul-17 INDUSTRY - Con. Staples BSE Code - 579 NSE Code - NESTLEIND NIFTY - 121 Company Data CMP 6789 Target Price 75 Previous Target Price 792 Upside 1 52wk Range H/L Mkt Capital (Rs Cr) Av. Volume
More informationNestle India NEUTRAL. Performance Highlights. CMP `4,387 Target Price - 2QCY2012 Result Update FMCG. Quarterly results. Investment Period -
2QCY2012 Result Update FMCG August 6, 2012 Nestle India Performance Highlights Quarterly results (` cr) 2QCY12 2QCY11 % yoy 1QCY12 % qoq Revenue 1,987 1,763 12.7 2,047 (3.0) EBITDA 429 344 24.5 457 (6.2)
More informationMarico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015
RESULTS REVIEW 4QFY15 29 APR 2015 Marico Kaya INDUSTRY FMCG CMP (as on 28 Apr 2015) Rs 1,635 Target Price Rs 1,823 Nifty 8,240 Sensex 27,226 KEY STOCK DATA Bloomberg MAKA IN No. of Shares (mn) 13 MCap
More informationConsolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in
More informationNear-term pressure, but long-term outlook positive
INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn)
More informationLarsen & Toubro Ltd.
Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 163. Larsen & Toubro Ltd. February 26, 2018 BSE Code: 500510 NSE Code: LT Reuters Code:
More informationMahindra & Mahindra. Source: Company Data; PL Research
Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty
More informationCMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630
4QFY17 Result Update June 02,2017 Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630 Decent Performance to Continue; Maintain Crompton Greaves Consumer Electricals (CGCEL) has delivered a
More informationCMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630
1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton
More informationHOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights
AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization
More informationVisaka Industries Ltd
Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%
More informationMaruti Suzuki. Source: Company Data; PL Research
Run continues, Royalty reduction positive ; Buy January 29, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs9,277
More informationTata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY. Stock Data. Stock Performance (%) Company Update IT Software India Research
Company Update IT Software India Research Tata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY Nifty 10,742 Sensex 35,319 Nifty PE 26.66 Sensex PE 23.48 Stock Data Sector IT Software BSE Code 500408 NSE
More informationCMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245
3QFY18 Result Update February 05, 2018 CMP* (Rs) 166 Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 Wage Provisioning, Lower in Plant Availability Impede Earnings Growth has delivered
More informationTitan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.
CMP* (Rs) 369 Market Cap. (Rs bn) 328 Free Float (%) 47 Shares O/S (mn) 888 Titan Company Back to Value Zone Validate Rating Upgrade Titan Company delivered decent performance in 2QFY17 despite reporting
More informationHOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research
2QCY17 Result Update July 18,2017 Market Cap. (Rs bn) 328 Free Float (%) 45 Shares O/S (mn) 188 Strong Performance on Better Volume and Firm Realizations reported better-than-estimated performance in 2QCY17
More informationHOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance
RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and
More informationBritannia Industries
Sustains momentum; Input cost gains peaked out November 09, 2015 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate Price
More informationAdani Ports & SEZ Rating: Target price: EPS:
Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT
More informationFinancials/Valu CY15 CY16 CY17E CY18E FY19E
14-Nov-17 INDUSTRY - Con. Staples BLOOMBERG - NEST IN BSE Code - 579 NSE Code - NESTLEIND NIFTY - 1225 Company Data CMP 7715 Target Price 845 Previous Target Price 75 Upside 1% 52wk Range H/L Mkt Capital
More informationBUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E
RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined
More informationApollo Tyres (APTY IN) Hungary Plant Visit: Finally benefiting from its greenfield expansion
INSTITUTIONAL EQUITY RESEARCH Apollo Tyres (APTY IN) Hungary Plant Visit: Finally benefiting from its greenfield expansion 20 June 2018 INDIA AUTOMOBILES Company Update Hungary plant visit: Key takeaways
More informationInitiating Coverage. Uflex Ltd.
2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and
More informationITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18. Volume No.. I Issue No. 186 ITC Ltd September 21, 2018 BSE Code: 500875 NSE Code: ITC Reuters Code: ITC.NS Bloomberg
More informationReliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014
INDUSTRY OIL & GAS Timing is everything COMPANY UPDATE 1 OCT 2014 Reliance Industries BUY CMP (as on 30 Sep 2014) Rs 945 Target Price Rs 1,100 Nifty 7,965 Sensex 26,631 KEY STOCK DATA Bloomberg/Reuters
More informationHUL. Q4FY17 Result Update Healthy performance, rich valuations. Sector: FMCG CMP: ` Recommendation: Hold
HUL QFY17 Result Update Healthy performance, rich valuations Sector: FMCG CMP: ` 1009 Recommendation: Hold Market Statistics Current stock price (`) 1,009 Shares O/S (cr.) 21. Mcap (`cr) 218,9 52W H/L
More informationSymphony Ltd. RESULT UPDATE 31st October 2017
. RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential
More informationCMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399
Company Update January 22, 2019 Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399 Multiple Growth Drivers in Place despite Near-term Headwinds Industries (SUNP) has released an investor
More informationMCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.
: price: EPS: Is commodity option a game changer for MCX? - Unlikely In the union budget 2015-16, the Finance Minister announced the much anticipated merger of SEBI and FMC. Given the powers accorded to
More informationCMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417
2QFY18 Result Update November 01, 2017 Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417 In-line Performance; Margins to Remain Strong (JSTL) has delivered an in-line performance in 2QFY18
More informationFinancials The wait for recoveries is getting longer
INSTITUTIONAL EQUITY RESEARCH Financials The wait for recoveries is getting longer 4 October 2018 INDIA Financials Q2FY19 Results Preview Our banking universe will see +11% yoy ( 4% qoq) growth in net
More informationFineotex Chemical Ltd
Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to
More informationFLASH NOTE Welspun India 31 Jan 17
Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 FLASH NOTE Welspun India 31 Jan 17 CMP (Rs) 76 TP (Rs) 81 Outperformer Key Figures
More informationBayer Cropscience (BYRCS IN)
(BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE
More informationHindustan Unilever Ltd.
. RESULT UPDATE 18 th July 2017 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 125 105 India Equity Institutional Research II Result Update - FY18 II 18th July, 2017 CMP INR 1158 Target INR 1206 MARKET
More informationBHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188
RESULTS REVIEW 1QFY15 13 AUG 2014 BHEL SELL INDUSTRY CAPITAL GOODS CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 Nifty 7,727 Sensex 25,881 KEY STOCK DATA Bloomberg/Reuters BHEL IN/BHEL.BO No. of Shares
More informationPrabhat Dairy Ltd. RESULT UPDATE 8th June, 2018
RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP
More informationITC. 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin. Sector: FMCG CMP: ` 289. Recommendation: BUY
ITC 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin Sector: FMCG CMP: ` 289 Recommendation: BUY Market statistics Current stock price (`) 289 Shares O/S (cr.) 1216.2 Mcap (`cr)
More informationMaruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research
In a league of its own ; Buy October 28, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs8,115 Target Price Rs9,250
More informationMphasis. Increased confidence on margins. Source: Company Data; PL Research
Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as
More informationQ4 EARNINGS REPORT Welspun India 25 Apr 17
Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer
More informationColgate-Palmolive India Ltd.
RESULT UPDATE 5th February, 2018 Feb-15 Aug-15 Feb-16 Aug-16 Feb-17 Aug-17 Feb-18 India Equity Institutional Research II Result Update - Q3FY18 II 5th February, 2018 CMP INR 1,120 MARKET DATA Target INR
More informationKey estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,
: price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be
More informationHindustan Unilever Ltd.
Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17. Volume No.. I Issue No. 152 Hindustan Unilever Ltd. December 1, 2017 BSE Code: 500696 NSE Code: HINDUNILVR Reuters
More informationKalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256
: price: EPS: How does our one year outlook change? We expect KPP s revenue (standalone) to grow by 21% y-o-y in FY17E backed by an order book of Rs. 91bn (1.7x FY17E book-to-bill). Both Transmission line
More informationSiemens. Railways and T&D driving inflows. Source: Company Data; PL Research
Railways and T&D driving inflows November 23, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,055 Target Price Rs1,230
More informationLARGE CAP & 1,970 BSE
Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)
More informationNestlé India Limited 20th Financial Analysts Meet - Gurgaon 30th November 2011
Nestlé India Limited 20 th Financial Analysts Meet - Gurgaon 30 th November 2011 Disclaimer This presentation may contain statements which reflect Management s current views and estimates and could be
More informationCummins India. Growth/margin bottoming. Source: Company Data; PL Research
Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%
More informationPersistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research
Growth led by Enterprise Retain BUY October 26, 20 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs669 Target Price Rs780
More information